Shukla S - Search Results

1

The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2.

Shukla S, Wu CP, Nandigama K, Ambudkar SV. Shukla S, et al. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3279-86. doi: 10.1158/1535-7163.MCT-07-0564. Epub 2007 Dec 7. Mol Cancer Ther. 2007. PMID: 18065489 Free PMC article.

2

Improving cancer chemotherapy with modulators of ABC drug transporters.

Shukla S, Ohnuma S, Ambudkar SV. Shukla S, et al. Curr Drug Targets. 2011 May;12(5):621-30. doi: 10.2174/138945011795378540. Curr Drug Targets. 2011. PMID: 21039338 Free PMC article. Review.

3

The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.

Macalou S, Robey RW, Jabor Gozzi G, Shukla S, Grosjean I, Hegedus T, Ambudkar SV, Bates SE, Di Pietro A. Macalou S, et al. Among authors: shukla s. Cell Mol Life Sci. 2016 May;73(9):1927-37. doi: 10.1007/s00018-015-2118-5. Epub 2015 Dec 26. Cell Mol Life Sci. 2016. PMID: 26708291 Free PMC article.

4

The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.

Shukla S, Robey RW, Bates SE, Ambudkar SV. Shukla S, et al. Biochemistry. 2006 Jul 25;45(29):8940-51. doi: 10.1021/bi060552f. Biochemistry. 2006. PMID: 16846237

5

Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin.

Chearwae W, Shukla S, Limtrakul P, Ambudkar SV. Chearwae W, et al. Among authors: shukla s. Mol Cancer Ther. 2006 Aug;5(8):1995-2006. doi: 10.1158/1535-7163.MCT-06-0087. Mol Cancer Ther. 2006. PMID: 16928820

6

Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure.

Robey RW, Shukla S, Steadman K, Obrzut T, Finley EM, Ambudkar SV, Bates SE. Robey RW, et al. Among authors: shukla s. Mol Cancer Ther. 2007 Jun;6(6):1877-85. doi: 10.1158/1535-7163.MCT-06-0811. Mol Cancer Ther. 2007. PMID: 17575116

7

ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions.

Calcagno AM, Kim IW, Wu CP, Shukla S, Ambudkar SV. Calcagno AM, et al. Among authors: shukla s. Curr Drug Deliv. 2007 Oct;4(4):324-33. doi: 10.2174/156720107782151241. Curr Drug Deliv. 2007. PMID: 17979652 Review.

8

New inhibitors of ABCG2 identified by high-throughput screening.

Henrich CJ, Robey RW, Bokesch HR, Bates SE, Shukla S, Ambudkar SV, Dean M, McMahon JB. Henrich CJ, et al. Among authors: shukla s. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3271-8. doi: 10.1158/1535-7163.MCT-07-0352. Mol Cancer Ther. 2007. PMID: 18089721 Free PMC article.

9

Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter.

Wu CP, Shukla S, Calcagno AM, Hall MD, Gottesman MM, Ambudkar SV. Wu CP, et al. Among authors: shukla s. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3287-96. doi: 10.1158/1535-7163.MCT-07-2005. Mol Cancer Ther. 2007. PMID: 18089722 Free PMC article.

10

Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.

Shukla S, Wu CP, Ambudkar SV. Shukla S, et al. Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):205-23. doi: 10.1517/17425255.4.2.205. Expert Opin Drug Metab Toxicol. 2008. PMID: 18248313 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,927 results

Search Page

Filters